Multiple Sclerosis Clinical Trials in Philadelphia

Showing 601-620 of 634 trials

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

NCT00377520

The intent of this protocol is to screen a new agent for activity in patients with advanced or recurrent endometrial carcinoma. This phase II trial is studying how well pemetrexed disodium works in treating patients with advanced or recurrent endometrial carcinoma.

NeoplasmsNeoplasms by SiteUrogenital Neoplasms+8 more

Eli Lilly and Company27 participantsStarted Sep 2006

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

NCT00063570

The purpose of the study is to determine if the two drugs can help patients feel better while causing the tumor to become smaller or disappear; evaluate the safety of giving both pemetrexed and gemcitabine in patients with advanced breast cancer.

Breast CancerBreast Neoplasms

Eli Lilly and Company73 participantsStarted Jul 2003

Aurora, Colorado, United States • Plantation, Florida, United States • Morrisville, North Carolina, United States +4 more locations

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Multiple Sclerosis Trials in Other Cities

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy

A Phase III Trial For Patients With Metastatic Breast Cancer

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Other Conditions in Philadelphia